Navigation Links
Omeros to Present at the Stifel Healthcare Conference 2013
Date:9/9/2013

SEATTLE, Sept. 9, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Stifel Healthcare Conference 2013 in Boston, Massachusetts this week. The presentation is scheduled for 2:40 p.m. Eastern time on Thursday, September 12, 2013.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has six clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.


'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015 Vermillion, Inc. (Nasdaq: ... focused on gynecologic disease, announced today it will ... the market open on Wednesday, March 25, 2015, ... at 8:30am Eastern. Conference Call & Webcast: ... Eastern/5:30am Pacific Domestic: , 800-753-9057International: , 913-981-5571Conference ID: ...
(Date:3/5/2015)... 5, 2015  BioPhotas, Inc., an FDA registered medical ... photo-therapeutic technologies to treat skin, muscle and joint conditions, ... Fi Fund to provide BioPhotas, flagship product, the ... management solutions.  Commenting on the alliance, ... used the Celluma at the Warrior Hope and Care ...
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... 2011 As the biopharmaceutical marketplace has evolved, leading ... to change as well. Specifically, Market Research is shifting ... shaping strategic objectives for key commercial groups. ... increasingly use new and innovative tools such as Webcams ...
... 10, 2011 American Medical Systems® (AMS) (Nasdaq: ... and therapies for male and female pelvic health, today ... of the Elevate® Anterior and Apical Prolapse Repair System. ... quantify, describe and stage pelvic support, was implemented in ...
Cached Medicine Technology:Strategic Role Becoming Critical Part of Market Research Function 2Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System 2
(Date:3/5/2015)... AZ (PRWEB) March 05, 2015 The ... various kinds of income to the Arizona economy each ... The report, Demonstrating the Economic Value of Maricopa County ... investment of the Maricopa district in fiscal year 2013-2014. ... Modeling Specialists International (EMSI), an organization that specializes ...
(Date:3/5/2015)... MS (PRWEB) March 05, 2015 At ... Basics and Beyond,” leaders in addiction treatment met today ... updates in best clinical practices. Among the numerous respected ... , who will address the role that pain medications ... and new evidence-based treatment options. , "It is hard ...
(Date:3/5/2015)... March 05, 2015 Taking center ... Fort Worth, Texas April 9-11th is IDRevolution hosted ... providing personalized nutrition. IDLife offers a variety ... This customized approach to vitamin supplementation is ... with a free HIPAA compliant online assessment and ...
(Date:3/5/2015)... Harrisburg, NC (PRWEB) March 05, 2015 ... of Physician Assistants’ (AAPA) review of Clearstream, ... AAPA determined that Clearstream’s MediDefense line of products—led ... of the AAPA’s Affinity Partner Program. , The ... physician assistants across all medical and surgical specialties ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Jordan Valley ... LifeVest® as a treatment option for sudden cardiac arrest. ... heart rhythm and can detect any life-threatening abnormalities. If ... alert the patient before delivering a treatment shock to ... Adam Elhaddi of Jordan Valley Medical Center and the ...
Breaking Medicine News(10 mins):Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3
... 8, 2011 Children who suffer from persistent or recurring ... are at risk of developing internalizing symptoms such as anxiety, ... review of chronic pain in children and adolescents in 20 ... are suffering from chronic pain and that girls suffer more ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Breast cancer ... have a 10 percent greater risk for developing cancer in ... woman receives her first diagnosis before age 40, new research ... [with this mutation] who have already had cancers are also ...
... Los Angeles, CA (DECEMBER 8, 2011) Young football players may ... study released in Journal of Child Neurology (JCN), ... and Dr. Meredith R. Golomb looked at various case studies ... and found some potential causes for strokes in young football ...
... THURSDAY, Dec. 8 (HealthDay News) -- Rats may have ... scroungers, a new study found that the rodents showed ... companions, even when they,re given the opportunity to eat ... in rodents suggests that this type of pro-social helping ...
... that combines an adjusted blood test with other factors including ... family history, can help up to one-quarter of men avoid ... Deaconess Medical Center-led research team says. Writing in a ... team led by Martin G. Sanda, MD, Director of the ...
... Lunenfeld Research Institute,s Drs. Frank Sicheri, Tony Pawson and ... the Ontario Cancer Institute, have uncovered the detailed architecture ... to the bone development disorder cherubism and involved in ... first structural insight into precisely how the enzyme correctly ...
Cached Medicine News:Health News:Chronic pain in children and adolescents becoming more common 2Health News:Breast Cancer Gene Puts Survivors at Higher Odds for Recurrence 2Health News:Rats Can Lend a Helping Paw to Others, Study Finds 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 3Health News:Toronto researchers obtain detailed molecular 'signature' for Tankyrase 2Health News:Toronto researchers obtain detailed molecular 'signature' for Tankyrase 3
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Reusable blunt cannula with luer hub. Cannula length is 32 mm....
Medicine Products: